Speech-Language Pathologists in Montgomery, AL Accepting Medicare

67 Speech-Language Pathologists found. Showing 61 - 67

Mrs. Emily Ann Stringfellow, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 560 S Lawrence St, Montgomery, AL 36104 Phone: 334-293-7242

Tammy Burlingame Trammell, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2125 E South Blvd, Montgomery, AL 36116 Phone: 334-288-0240

Karen Poole, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 527 Buckingham Dr, Montgomery, AL 36116 Phone: 334-284-4604    Fax: 334-286-9102

Mrs. Darla Denise Hahn, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 340 Mendel Pkwy W, Montgomery, AL 36117 Phone: 334-532-0220    Fax: 334-532-0221

Katie Black Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2185 Normandie Dr, Montgomery, AL 36111 Phone: 334-395-4489

Prof. Amy Catherine Ogburn Yeager, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7041 Senators Drive,, Liberal Arts Bldg Rm 110, Montgomery, AL 36117 Phone: 334-244-3410    Fax: 334-244-3906

Jennifer Brooke Mullins, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 340 Mendel Pkwy W, Montgomery, AL 36117 Phone: 334-532-0220

News Archive

Decline in atillbirths

The rate of fetal deaths, also known as stillbirths, occurring at 20 weeks of gestation or more declined substantially between 1990 and 2003, according to a report by the Centers for Disease Control and Prevention (CDC).

Experts identify new gene that could help development of human fertility treatments

Experts from Durham University have identified a new gene that could help the development of fertility treatments in humans in the future.

ABAM Foundation accredits nine additional fellowship programs to expand training in addiction medicine

The American Board of Addiction Medicine Foundation today announced the accreditation of nine additional fellowship programs to train addiction medicine physicians. With the addition of these programs, the total number of ABAM Foundation accredited training programs has reached 36.

Added benefit of dabrafenib not proven

Dabrafenib has been approved in Germany since August 2013 for the treatment of advanced melanoma. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the appropriate comparator therapy.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3
• 4(current)